Uncategorized Archives - Page 82 of 145

TuesdayAug 03, 2021 9:30 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Is ‘One to Watch’

InMed has a world class leadership team with a successful track record of drug development and commercialization The company recently announced closing of a $12 million private placement InMed has a solid and expanding intellectual property portfolio with multiple patents filed The company recently signed an LOI to acquire rare cannabinoids manufacturer BayMedica InMed retains all commercial rights to its IntegraSyn manufacturing system InMed has filed clinical trial applications in several countries as part of a Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa The consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to…

MondayAug 02, 2021 12:26 pm

Study Finds Extensive Variations in Cost, Transparency of Thyroid Cancer Care

A mandate from the Centers for Medicare and Medicaid Services directed that from Jan. 1, 2021, all hospitals in the United States provide pricing information online about their services and items. The objective of this mandate is to help inform patients about the cost of procedures and services before they receive them. Researchers from Brigham and Women’s Hospital and Massachusetts Eye and Ear used this data to examine price variation and transparency for thyroid cancer treatment. They discovered that both price and transparency differed greatly, with the costs of various services having huge variations and only one-half of the cancer…

MondayAug 02, 2021 9:30 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Is ‘One to Watch’

AnPac Bio-Medical Science Co. Ltd. is a biotechnology company focused on early cancer screening and detection The company aims to develop, distribute and deploy its Cancer Differentiation Analysis (“CDA”) technology to change the way people approach cancer screening CDA is powered by a database of over 200,000 samples and cases, providing a new way to approach disease and cancer screening The company’s management team comprises professionals in both the United States and China who are knowledgeable and well educated in cancer screening and detection The global cancer diagnostics market is expected to reach $249.6 billion by 2026 AnPac Bio-Medical Science…

FridayJul 30, 2021 11:11 am

Brain Biomarkers May Help to Accurately Predict ADHD Diagnosis

Research that was published in Frontiers in Physiology has found that communication among different regions in the brain, which is referred to as brain connectivity, could possibly serve as a biomarker for attention-deficit hyperactivity disorder (“ADHD”). For the study, researchers from the University of Buffalo in collaboration with the University of Cincinnati used machine-learning classifiers to identify grown-ups who had been diagnosed with ADHD during their childhood with 99% accuracy. The researchers note that these findings may be useful in helping clinicians find proper treatments that address the specific needs for each patient and may also increase the ease with…

FridayJul 30, 2021 10:34 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) Launches Second Stage of Manufacturing of Ibogaine for Clinical Research

The company has filed patent applications for two routes of chemical synthesis of ibogaine – offering potential advantages of improved isomeric purity, chiral purity, and easily isolated intermediate compounds Preliminary data indicates that the drug shows promise as a treatment for neuropathic pain and migraines, as well as the treatment of addiction The company is positioned to engage several markets, including digital therapeutics and research Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (“MINDCURE”), a diversified life sciences company at the forefront of the mental health industry, recently announced the launch of its second manufacturing stage of pharmaceutical-grade ibogaine to be…

FridayJul 30, 2021 10:04 am

Brain Scientific Inc. (BRSF) Poised to Benefit as Rapidly Growing Brain-Computer Interface Field Drives EEG Growth

Brain-Computer Interface (“BCI”) market is expanding rapidly, expected to double to USD 406 billion by 2026 BCI technology, designed to acquire brain signals, analyze and translate them into commands, is one of key driving forces behind EEG technology growth Brain Scientific appears poised to capitalize on this novel technology as its applications expand from medical settings to training, consumer engagement, entertainment, and more The Brain-Computer Interface (“BCI”) field is growing rapidly, representing one of the main driving factors behind the expansion of EEG technology. As the provider of EEG technology, Brain Scientific (OTCQB: BRSF) appears well placed to leverage this…

ThursdayJul 29, 2021 2:39 pm

Study Finds That Plant-Based Diets May Be Better for Heart Health

A recent study has discovered that diets rich in plant foods are better than low-fat diets when it comes to decreasing the risk of stroke and heart disease. The study monitored more than 5,000 Americans, with the scientists finding that individuals who ate diets low in saturated fat had lower LDL levels. Saturated fat is known to increase LDL cholesterol levels and is mostly found in animal products. LDL cholesterol, or low-density lipoprotein, is considered a bad cholesterol as it contributes to fatty buildup in the arteries. However, the researchers note that lower LDL levels didn’t translate to a lower risk…

ThursdayJul 29, 2021 9:30 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Proprietary Imaging System Set to Advance Bladder Cancer Visualization

Approximatively 75-85% of patients with confirmed cases of bladder cancer are diagnosed with non-muscle invasive (“NMIBC”) Imagin Medical’s innovative technology is targeting this type of bladder cancer and set to be completed in 2022 Blue light cystoscopy helps surgeons visualize the cancerous cells that are not detected by white light, enabling an improved resection Non-muscle-invasive bladder cancer (“NMIBC”) is a type of bladder cancer that has not infiltrated the other muscle tissues inside the bladder or spread to the lymph nodes. Approximately 75-85% of patients presenting with bladder cancer are diagnosed with NMIBC. The most common symptoms of NMIBC which…

ThursdayJul 29, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Globally Unlocking Data in the Complete Therapeutic Plant Lifecycle

Providing a holistic approach to therapeutic plant treatment by unlocking data from seed to consumption RYAH Group is providing needed dosing devices globally to drive innovation and deliver cutting edge plant-based medical solutions globally With over 200k registered users, RYAH Group is one of the largest plant-based medicine databases in the world and regularly releases and shares valuable insights collected RYAH Group (CSE: RYAH), formerly RYAH Medtech, is leading the way forward by providing a holistic approach to therapeutic plant treatment by unlocking the data in the complete plant lifecycle (seed to consumption). Known for its high-quality information and digital…

WednesdayJul 28, 2021 10:36 am

Researchers Discover New Phase in Stem Cell Cycle That May Help Develop Tumor Treatments

Researchers from Arizona State University are conducting a study on the life cycle of stem cells. The study may be useful in the development of new techniques for treating brain cancer. The research was reported in the “Molecular Systems Biology” journal. Assistant professor of biomedical engineering from the institution’s school of engineering Christopher Plaisier stated that the research team had discovered a new phase in the cycle during their study. This new information was discovered through an alliance with associate professor Patrick Paddison from the Fred Hutchinson Cancer Research Center and University of Washington’s assistant professor of neurological surgery Dr.…